Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Feb;78(2):149–154. doi: 10.1136/bjo.78.2.149

Human T lymphotropic virus type 1 uveitis.

M Mochizuki 1, K Tajima 1, T Watanabe 1, K Yamaguchi 1
PMCID: PMC504720  PMID: 8123625

Abstract

The human retroviruses, HTLV-I and HIV, are playing clinically important roles in a variety of ocular disorders, particularly in uveitis. Both viruses are integrated in the genome of infected T cells. HIV-I infection causes the death of the infected T cells, thereby affecting the host defence system and causing AIDS. Subsequent opportunistic infections of ocular tissues, such as CMV retinitis, are a serious problem in clinical ophthalmology all over the world. Another human retrovirus, HTLV-I, has been known as the causative agent of T cell malignancies (ATL and T cell lymphoma) and chronic myelopathy (HAM/TSP), and is now recognised as a causative agent for a specific type of intraocular inflammation characterised by vitreous opacities with mild iritis and mild retinal vasculitis (HTLV-I uveitis). The mechanism by which HTLV-I causes uveitis is still unknown, but our recent data suggest that it is most probably an immune mediated mechanism by activated CD4 T cells infected with the virus. HTLV-I uveitis, therefore, may implicate a significant role of retroviruses in autoimmune diseases and further the pathogenesis of diseases with infection/autoimmune overlap.

Full text

PDF
149

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araki S., Mochizuki M., Yamaguchi K., Watanabe T., Ono A., Yoshimura K., Shirao M., Miyata N. Familial clustering of human T lymphotropic virus type 1 uveitis. Br J Ophthalmol. 1993 Nov;77(11):747–748. doi: 10.1136/bjo.77.11.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartholomew C., Cleghorn F., Charles W., Ratan P., Roberts L., Maharaj K., Jankey N., Daisley H., Hanchard B., Blattner W. HTLV-I and tropical spastic paraparesis. Lancet. 1986 Jul 12;2(8498):99–100. doi: 10.1016/s0140-6736(86)91626-0. [DOI] [PubMed] [Google Scholar]
  3. Bartholomew C., Saxinger W. C., Clark J. W., Gail M., Dudgeon A., Mahabir B., Hull-Drysdale B., Cleghorn F., Gallo R. C., Blattner W. A. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA. 1987 May 15;257(19):2604–2608. [PubMed] [Google Scholar]
  4. Bhagavati S., Ehrlich G., Kula R. W., Kwok S., Sninsky J., Udani V., Poiesz B. J. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N Engl J Med. 1988 May 5;318(18):1141–1147. doi: 10.1056/NEJM198805053181801. [DOI] [PubMed] [Google Scholar]
  5. Bloch-Michel E., Nussenblatt R. B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987 Feb 15;103(2):234–235. doi: 10.1016/s0002-9394(14)74235-7. [DOI] [PubMed] [Google Scholar]
  6. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  7. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K. I., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ishimoto S., Sakai Y., Ishibashi T., Khono T., Inomata H., Itoyama Y. [Interferon-alpha for the treatment of retinal vasculitis associated with human T-lymphotropic virus type I myelopathy (HAM)]. Nippon Ganka Gakkai Zasshi. 1990 Aug;94(8):769–773. [PubMed] [Google Scholar]
  9. Itoyama Y., Kira J., Fujii N., Goto I., Yamamoto N. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy. Ann Neurol. 1989 Aug;26(2):257–262. doi: 10.1002/ana.410260212. [DOI] [PubMed] [Google Scholar]
  10. Itoyama Y., Minato S., Kira J., Goto I., Sato H., Okochi K., Yamamoto N. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology. 1988 Aug;38(8):1302–1307. doi: 10.1212/wnl.38.8.1302. [DOI] [PubMed] [Google Scholar]
  11. Jacobson S., Raine C. S., Mingioli E. S., McFarlin D. E. Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature. 1988 Feb 11;331(6156):540–543. doi: 10.1038/331540a0. [DOI] [PubMed] [Google Scholar]
  12. Kalyanaraman V. S., Sarngadharan M. G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R. C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. 1982 Nov 5;218(4572):571–573. doi: 10.1126/science.6981847. [DOI] [PubMed] [Google Scholar]
  13. Kawano F., Tsukamoto A., Satoh M., Sanada I., Shido T., Suzushima H., Asou N., Takatsuki K. HTLV-1 associated myelopathy/tropical spastic paraparesis with adult T-cell leukemia. Leukemia. 1992 Jan;6(1):66–67. [PubMed] [Google Scholar]
  14. Kondo T., Kono H., Miyamoto N., Yoshida R., Toki H., Matsumoto I., Hara M., Inoue H., Inatsuki A., Funatsu T. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer. 1989 Jun 15;43(6):1061–1064. doi: 10.1002/ijc.2910430618. [DOI] [PubMed] [Google Scholar]
  15. Lairmore M. D., Jacobson S., Gracia F., De B. K., Castillo L., Larreategui M., Roberts B. D., Levine P. H., Blattner W. A., Kaplan J. E. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8840–8844. doi: 10.1073/pnas.87.22.8840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lee H., Swanson P., Shorty V. S., Zack J. A., Rosenblatt J. D., Chen I. S. High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science. 1989 Apr 28;244(4903):471–475. doi: 10.1126/science.2655084. [DOI] [PubMed] [Google Scholar]
  17. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981 Dec 24;294(5843):770–771. doi: 10.1038/294770a0. [DOI] [PubMed] [Google Scholar]
  18. Mochizuki M., Watanabe T., Yamaguchi K., Tajima K., Yoshimura K., Nakashima S., Shirao M., Araki S., Miyata N., Mori S. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis. 1992 Oct;166(4):943–944. doi: 10.1093/infdis/166.4.943. [DOI] [PubMed] [Google Scholar]
  19. Mochizuki M., Watanabe T., Yamaguchi K., Takatsuki K., Yoshimura K., Shirao M., Nakashima S., Mori S., Araki S., Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992 Mar;83(3):236–239. doi: 10.1111/j.1349-7006.1992.tb00092.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mochizuki M., Watanabe T., Yamaguchi K., Yoshimura K., Nakashima S., Shirao M., Araki S., Takatsuki K., Mori S., Miyata N. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol. 1992 Aug 15;114(2):123–129. doi: 10.1016/s0002-9394(14)73974-1. [DOI] [PubMed] [Google Scholar]
  21. Mochizuki M., Yamaguchi K., Takatsuki K., Watanabe T., Mori S., Tajima K. HTLV-I and uveitis. Lancet. 1992 May 2;339(8801):1110–1110. doi: 10.1016/0140-6736(92)90699-4. [DOI] [PubMed] [Google Scholar]
  22. Nakao K., Matsumoto M., Ohba N. Seroprevalence of antibodies to HTLV-I in patients with ocular disorders. Br J Ophthalmol. 1991 Feb;75(2):76–78. doi: 10.1136/bjo.75.2.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nakao K., Ohba N., Isashiki M., Isashiki Y., Unoki K., Osame M. Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy. Jpn J Ophthalmol. 1989;33(4):383–391. [PubMed] [Google Scholar]
  24. Nakao K., Ohba N., Matsumoto M. Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(4):472–481. [PubMed] [Google Scholar]
  25. Nishimoto N., Yoshizaki K., Eiraku N., Machigashira K., Tagoh H., Ogata A., Kuritani T., Osame M., Kishimoto T. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci. 1990 Jul;97(2-3):183–193. doi: 10.1016/0022-510x(90)90217-b. [DOI] [PubMed] [Google Scholar]
  26. Ohba N., Matsumoto M., Sameshima M., Kabayama Y., Nakao K., Unoki K., Uehara F., Kawano K., Maruyama I., Osame M. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(1):1–12. [PubMed] [Google Scholar]
  27. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987 Feb;21(2):117–122. doi: 10.1002/ana.410210203. [DOI] [PubMed] [Google Scholar]
  28. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986 May 3;1(8488):1031–1032. doi: 10.1016/s0140-6736(86)91298-5. [DOI] [PubMed] [Google Scholar]
  29. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Popovic M., Reitz M. S., Jr, Sarngadharan M. G., Robert-Guroff M., Kalyanaraman V. S., Nakao Y., Miyoshi I., Minowada J., Yoshida M., Ito Y. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature. 1982 Nov 4;300(5887):63–66. doi: 10.1038/300063a0. [DOI] [PubMed] [Google Scholar]
  31. Rodgers-Johnson P., Gajdusek D. C., Morgan O. S., Zaninovic V., Sarin P. S., Graham D. S. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet. 1985 Nov 30;2(8466):1247–1248. doi: 10.1016/s0140-6736(85)90778-0. [DOI] [PubMed] [Google Scholar]
  32. Salahuddin S. Z., Markham P. D., Lindner S. G., Gootenberg J., Popovic M., Hemmi H., Sarin P. S., Gallo R. C. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science. 1984 Feb 17;223(4637):703–707. doi: 10.1126/science.6320367. [DOI] [PubMed] [Google Scholar]
  33. Sasaki K., Morooka I., Inomata H., Kashio N., Akamine T., Osame M. Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy. Br J Ophthalmol. 1989 Oct;73(10):812–815. doi: 10.1136/bjo.73.10.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tachibana N., Okayama A., Kusune E., Yokota T., Shishime E., Tsuda K., Matano H. [Anti-human T-cell leukemia virus antibody distribution in Miyazaki Prefecture]. Kansenshogaku Zasshi. 1984 Aug;58(8):717–722. doi: 10.11150/kansenshogakuzasshi1970.58.717. [DOI] [PubMed] [Google Scholar]
  35. Tajima K., Kamura S., Ito S., Ito M., Nagatomo M., Kinoshita K., Ikeda S. Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan. Int J Cancer. 1987 Dec 15;40(6):741–746. doi: 10.1002/ijc.2910400605. [DOI] [PubMed] [Google Scholar]
  36. Tsujimoto A., Teruuchi T., Imamura J., Shimotohno K., Miyoshi I., Miwa M. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med. 1988 Feb;5(1):29–42. [PubMed] [Google Scholar]
  37. Yoshida M., Osame M., Usuku K., Matsumoto M., Igata A. Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting. Lancet. 1987 May 9;1(8541):1085–1086. doi: 10.1016/s0140-6736(87)90506-x. [DOI] [PubMed] [Google Scholar]
  38. Yoshimura K., Mochizuki M., Araki S., Miyata N., Yamaguchi K., Tajima K., Watanabe T. Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis. Am J Ophthalmol. 1993 Aug 15;116(2):156–163. doi: 10.1016/s0002-9394(14)71279-6. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES